Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.6 (
RNA polymerase
)
34,946
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Transcription of the gene encoding the transcriptional coactivator
Oct-binding factor 1
(
OBF-1
)/OCA-B/Bob.1 is largely restricted to B cells. During B cell development
OBF-1
expression shows two peaks, one in immature B cells in the bone marrow and the other in germinal center B cells. Promoter analysis has identified a cAMP response element (CRE)-binding site present in the
OBF-1
proximal promoter that is crucial for activity in B cells and for the induction of
OBF-1
expression upon stimulation with CD40 ligand/IL-4. Here we address the question of how transcription of the
OBF-1
gene is restricted to B cells. Surprisingly, in transient transfection assays the
OBF-1
proximal promoter exhibited an equally strong activity in B and non-B cells. In contrast, upstream promoter regions displayed B cell-specific properties, partly overlapping with DNaseI hypersensitive sites identified in this study. In mice, expression of a neomycin resistance gene under the control of a Polyoma enhancer/TK promoter cassette was restricted to B cells when integrated into the
OBF-1
locus, but was ubiquitous when integrated into two other loci, Oct-1 or the large subunit of
RNA polymerase II
.Therefore, lineage commitment of the
OBF-1
gene is promoter independent and is achieved by regulating the entire locus in a B cell-specific manner.
...
PMID:The OBF-1 gene locus confers B cell-specific transcription by restricting the ubiquitous activity of its promoter. 1451 70